Researchers have been excited about Retatrutide , a novel dual agonist showing promising results in clinical trials for body loss . It works by modulating several pathways : GLP-1 and GIP, that , when https://jimjlpj131629.life3dblog.com/39283663/a-new-hope-for-body-loss